Brokerages Set LifePoint Health Inc (LPNT) Price Target at $59.17

Shares of LifePoint Health Inc (NASDAQ:LPNT) have received a consensus recommendation of “Hold” from the twenty ratings firms that are covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $59.17.

A number of equities analysts have recently issued reports on LPNT shares. SunTrust Banks set a $60.00 price target on LifePoint Health and gave the stock a “hold” rating in a research note on Thursday, October 12th. BMO Capital Markets started coverage on LifePoint Health in a research note on Monday, October 16th. They issued a “market perform” rating and a $59.00 price target on the stock. Raymond James Financial restated a “market perform” rating on shares of LifePoint Health in a research note on Monday, October 30th. Robert W. Baird set a $55.00 price target on LifePoint Health and gave the stock a “buy” rating in a research note on Monday, October 30th. Finally, Citigroup dropped their price target on LifePoint Health from $70.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, October 30th.

In other LifePoint Health news, Director Marguerite Kondracke sold 3,907 shares of the firm’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $44.73, for a total transaction of $174,760.11. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 8.76% of the stock is currently owned by insiders.

Large investors have recently bought and sold shares of the business. American Century Companies Inc. increased its holdings in shares of LifePoint Health by 7.7% in the third quarter. American Century Companies Inc. now owns 3,630,487 shares of the company’s stock worth $210,205,000 after purchasing an additional 260,944 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of LifePoint Health by 1.3% in the second quarter. Vanguard Group Inc. now owns 3,310,467 shares of the company’s stock worth $222,299,000 after purchasing an additional 43,504 shares during the last quarter. LSV Asset Management increased its holdings in shares of LifePoint Health by 83.5% in the second quarter. LSV Asset Management now owns 1,994,557 shares of the company’s stock worth $133,934,000 after purchasing an additional 907,469 shares during the last quarter. State Street Corp increased its holdings in shares of LifePoint Health by 2.1% in the second quarter. State Street Corp now owns 1,132,914 shares of the company’s stock worth $76,075,000 after purchasing an additional 23,552 shares during the last quarter. Finally, Victory Capital Management Inc. increased its holdings in shares of LifePoint Health by 19.3% in the third quarter. Victory Capital Management Inc. now owns 973,978 shares of the company’s stock worth $56,393,000 after purchasing an additional 157,831 shares during the last quarter. 99.18% of the stock is currently owned by institutional investors and hedge funds.

Shares of LifePoint Health (LPNT) traded up $0.40 on Thursday, reaching $49.00. The company’s stock had a trading volume of 197,950 shares, compared to its average volume of 464,255. The company has a current ratio of 1.85, a quick ratio of 1.65 and a debt-to-equity ratio of 1.24. LifePoint Health has a 1-year low of $42.50 and a 1-year high of $70.95. The stock has a market cap of $1,950.00, a P/E ratio of 11.61, a price-to-earnings-growth ratio of 1.27 and a beta of 0.67.

LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings results on Friday, October 27th. The company reported $0.80 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.95 by ($0.15). The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.60 billion. LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The business’s quarterly revenue was down .7% on a year-over-year basis. During the same quarter last year, the business earned $0.94 earnings per share. equities analysts expect that LifePoint Health will post 3.64 earnings per share for the current fiscal year.

LifePoint Health declared that its board has authorized a stock buyback plan on Friday, October 27th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board believes its shares are undervalued.

ILLEGAL ACTIVITY WARNING: “Brokerages Set LifePoint Health Inc (LPNT) Price Target at $59.17” was originally posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another site, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.com-unik.info/2017/12/24/brokerages-set-lifepoint-health-inc-lpnt-price-target-at-59-17.html.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit